Condition 1: Neurogenic bladder. Condition 2: Neurogenic bladder dysfunction due to cauda equina syndrom. Neuromuscular dysfunction of bladder, unspecified Other specified diseases of spinal cord
Conditions
Interventions
Intervention group: Patients who have the inclusion criteria to enrol the study,first will undergo primary urodynamic study with DELPHIS IP,MODEL 94_RO1P_BT manufactured by LABORIE MEDICAL TECHNOLOGIE
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: Patients under the age of 18 Affected with Spastic Neurogenic Bladder Refer to Mofid Children's Hospital Under treatment with Clean Intermittent Catheterization Under treatment with maximal medical therapy with anti-cholinergic drugs Reveal anti-cholinergic drugs related complications Reveal anti-cholinergic drugs resistance
Exclusion criteria
Exclusion criteria: Patients who have been undergone prior bladder augmentation surgery Patients that their parents or their legal guardian don't accept their study enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bladder capacity after injection. Timepoint: Before intervention and 3 months after that. Method of measurement: Mofid children Hospital urodynamic measurement device ,model DELPHIS IP, MODEL: 94_RO1P_BT;Manufactured by LABORIE MEDICAL TECHNOLOGIES.;Hours of not demanding diaper change. Timepoint: Before and 3 months after Botox injection. Method of measurement: Interview with parents. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaran Lotfollahzadeh
Shahid Beheshti University of Medical Sciences
Outcome results
None listed